Engagement at CDMO Live 2025
CHASKA, Minn. — Lifecore Biomedical, Inc. (NASDAQ: LFCR), a prominent contract development and manufacturing organization, is gearing up for its participation in the much-anticipated CDMO Live 2025 conference. This event, regarded as a leading platform in the biopharma outsourcing sector, is scheduled to happen on May 7-8 in an inspiring setting, where professionals gather to foster collaboration and innovation.
Transforming Quality Management
Jackie Klecker, who serves as Lifecore's executive vice president overseeing quality and development services, will be at the forefront of a significant discussion at the conference. With over 30 years of extensive experience in quality assurance and development, Ms. Klecker aims to lead a crucial dialogue about enhancing quality management within CDMO partnerships.
Innovative Approaches to Quality
The session, titled Quality as a Catalyst: Accelerating CDMO Success Through Quality Management, is designed to shed light on how organizations can redefine quality management, shifting it from a potential hurdle to a vital component driving partnership success. This reflects a growing trend in the industry where quality is not merely a compliance obligation, but a competitive edge.
Conference Details and Insights
During her session, which will take place on May 7 at noon local time, Jackie Klecker will engage with industry leaders and experts to explore strategies that enhance operational efficiency through better quality management. This discourse is not just a sharing of standards but an opportunity to cultivate thorough understanding and innovative practices within the CDMO frameworks.
About CDMO Live 2025
The CDMO Live 2025 conference serves as a prestigious meeting point for biopharmaceutical leaders and thinkers to network, share insights, and forge partnerships that propel the industry forward. Through various sessions and discussions, attendees will explore groundbreaking ideas that shape the future of pharmaceutical manufacturing and development.
The Lifecore Edge
Lifecore Biomedical stands out in the CDMO landscape with its rich history and expertise in developing, filling, and finishing sterile injectable products. The company boasts over 40 years of experience as a trusted partner for both established and emerging biopharmaceutical entities.
Commitment to Innovation
Through its specialization in injectable-grade hyaluronic acid and complex formulations, Lifecore is uniquely positioned to help accelerate the timeline of new therapeutic solutions reaching market. Its commitment to quality and excellence is reflected in every aspect of its operations, making it a leader in the biopharmaceutical supply chain.
Looking Ahead
As Lifecore Biomedical prepares for the CDMO Live 2025 conference, it is poised to demonstrate its ongoing dedication to elevating industry standards and partnership potential. With the evolving landscape of biotechnology, the role of quality in development and manufacturing processes becomes increasingly critical for success.
Frequently Asked Questions
What is the CDMO Live 2025 conference about?
The CDMO Live 2025 conference focuses on partnership opportunities and innovations in the biopharmaceutical outsourcing industry.
Who is Jackie Klecker?
Jackie Klecker is the executive vice president at Lifecore Biomedical, with extensive experience in quality assurance and manufacturing.
What will Jackie Klecker discuss at the conference?
She will lead a discussion on transforming quality management into a strategic advantage within CDMO partnerships.
Why is quality management important in CDMOs?
Effective quality management helps improve operational efficiency and ensures compliance, thereby establishing a competitive edge in the market.
How can I learn more about Lifecore Biomedical?
You can visit Lifecore's website for more information regarding their services and area of expertise.
